5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 47.69▲ | 47.69▲ | 47.69▲ | 47.63▲ | 33.75▲ |
MA10 | 47.69▲ | 47.69▲ | 47.68▲ | 39.29▲ | 27.21▲ |
MA20 | 47.69▲ | 47.68▲ | 47.66▲ | 31.19▲ | 22.11▲ |
MA50 | 47.69▲ | 47.65▲ | 43.79▲ | 24.65▲ | 20.58▲ |
MA100 | 47.68▲ | 42.53▲ | 33.93▲ | 20.74▲ | 21.23▲ |
MA200 | 47.66▲ | 33.08▲ | 27.99▲ | 19.07▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.032▼ | -0.385▼ | 2.263▲ | 3.079▲ |
RSI | 54.489▲ | 74.156▲ | 88.545▲ | 94.418▲ | 85.509▲ |
STOCH | 66.667 | 67.222 | 75.185 | 99.747▲ | 91.905▲ |
WILL %R | -50.000 | -25.000▲ | -13.636▲ | -0.059▲ | -0.046▲ |
CCI | 107.333▲ | 71.854 | 101.275▲ | 78.084 | 258.768▲ |
Thursday, September 11, 2025 01:19 AM
Detailed price information for Tourmaline Bio Inc (TRML-Q) from The Globe and Mail including charting and trades.
|
Tuesday, September 09, 2025 11:42 AM
Novartis AG acquires Tourmaline Bio, Inc. for $1.4B to boost its cardiovascular pipeline with pacibekitug. Click here for more on NVS and TRML stocks.
|
Tuesday, September 09, 2025 10:29 AM
Investing.com-- Novartis AG (SIX: NOVN) will buy Tourmaline Bio Inc (NASDAQ: TRML) for about $1.4 billion in cash, adding the U.S. biotech’s experimental treatment for cardiovascular disease to its ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 47.67 | 47.71 | 47.66 | 47.695 | 575,330 |
15/09/25 | 47.63 | 47.70 | 47.62 | 47.65 | 924,319 |
12/09/25 | 47.60 | 47.695 | 47.59 | 47.61 | 988,444 |
11/09/25 | 47.60 | 47.64 | 47.58 | 47.60 | 1,714,465 |
10/09/25 | 47.62 | 47.64 | 47.58 | 47.60 | 3,047,895 |
09/09/25 | 47.615 | 47.69 | 47.57 | 47.64 | 22,600,695 |
08/09/25 | 26.865 | 30.505 | 26.309 | 30.18 | 1,028,964 |
05/09/25 | 25.80 | 28.455 | 25.73 | 26.74 | 445,990 |
04/09/25 | 25.11 | 25.53 | 24.72 | 25.10 | 339,245 |
03/09/25 | 23.53 | 25.39 | 23.22 | 25.11 | 288,875 |
|
|
||||
|
|
||||
|
|